FDA Recalls Chlorthalidone Tablets Over Dissolution Failure

The U.S. Food and Drug Administration has announced a new nationwide voluntary Class II recall of specific lots of chlorthalidone 25 mg tablets manufactured by Inventia Healthcare Limited due to failed dissolution specifications. This September initiative involves more than 13,000 bottles from one lot that may not dissolve properly in the body as intended. The FDA classifies this issue as remote for serious health consequences but potentially temporary or medically reversible if exposure occurs. Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention by helping kidneys shed excess water and salt, with possible side effects including dizziness and electrolyte changes. Patients are advised to contact their healthcare provider before stopping or altering their medication regimen.